Clevudine (
INN) is an antiviral drug for the treatment of
hepatitis B (HBV). It is already approved for HBV in
South Korea and the
Philippines. It is marketed by Bukwang Pharmaceuticals in South Korea under the tradenames Levovir and Revovir.
Researchers in South Korea are testing clevudine at lower doses in combination with
adefovir for continued use.
It is a
nucleoside analog.
References
Nucleoside analog reverse transcriptase inhibitors
Pyrimidinediones
Organofluorides
Arabinosides
Halohydrins
Hydroxymethyl compounds
{{antiinfective-drug-stub